Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebocontrolled study
Personalized care plans ensure that therapy remains appropriate for each individual
Ajona D, Ortiz-Espinosa S, Lozano T, Exposito F, Calvo A, Valencia K, et al
To investigate the effects of pasireotide, H-89, ESI-09, and PTX, the cells were preincubated with pasireotide for 2.5 h, PTX for 46 h, H-89, and ESI-09, respectively
The test analyzes 14 peptide pathways and 150+ genetic insights, including GLP1R sensitivity variants and metabolic genes
FSA and HSA funds can typically be used for both consultations and medications